Literature DB >> 19934113

Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.

Sonia Clavero1, David F Bishop, Mark E Haskins, Urs Giger, Raili Kauppinen, Robert J Desnick.   

Abstract

Human acute intermittent porphyria (AIP), the most common acute hepatic porphyria, is an autosomal dominant inborn error of heme biosynthesis due to the half-normal activity of hydroxymethylbilane synthase (HMB-synthase). Here, we describe the first naturally occurring animal model of AIP in four unrelated cat lines who presented phenotypically as congenital erythropoietic porphyria (CEP). Affected cats had erythrodontia, brownish urine, fluorescent bones, and markedly elevated urinary uroporphyrin (URO) and coproporphyrin (COPRO) consistent with CEP. However, their uroporphyrinogen-III-synthase (URO-synthase) activities (deficient in CEP) were normal. Notably, affected cats had half-normal HMB-synthase activities and elevated urinary 5-aminolevulinic acid (ALA) and porphobilinogen (PBG), the deficient enzyme and accumulated metabolites in human AIP. Sequencing the feline HMB-synthase gene revealed different mutations in each line: a duplication (c.189dupT), an in-frame 3 bp deletion (c.842_844delGAG) identical to that causing human AIP and two missense mutations, c.250G>A (p.A84T) and c.445C>T (p.R149W). Prokaryotic expression of mutations c.842_844delGAG and c.445C>T resulted in mutant enzymes with <1% wild-type activity, whereas c.250G>A expressed a stable enzyme with approximately 35% of wild-type activity. The discolored teeth from the affected cats contained markedly elevated URO I and III, accounting for the CEP-like phenocopy. In three lines, the phenotype was an autosomal dominant trait, while affected cats with the c.250G>A (p.A84T) mutation were homozygous, a unique recessive form of AIP. These animal models may permit further investigation of the pathogenesis of the acute, life-threatening neurological attacks in human AIP and the evaluation of therapeutic strategies. GenBank Accession Numbers: GQ850461-GQ850464.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19934113      PMCID: PMC2807367          DOI: 10.1093/hmg/ddp525

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site.

Authors:  G V Louie; P D Brownlie; R Lambert; J B Cooper; T L Blundell; S P Wood; M J Warren; S C Woodcock; P M Jordan
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

2.  Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase gene.

Authors:  D H Llewellyn; S J Smyth; G H Elder; A C Hutchesson; J M Rattenbury; M F Smith
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 3.  Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.

Authors:  H L Bonkovsky; G F Barnard
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

Review 4.  The three-dimensional structures of mutants of porphobilinogen deaminase: toward an understanding of the structural basis of acute intermittent porphyria.

Authors:  P D Brownlie; R Lambert; G V Louie; P M Jordan; T L Blundell; M J Warren; J B Cooper; S P Wood
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

5.  A retrospective study of a patient with homozygous form of acute intermittent porphyria.

Authors:  G J Beukeveld; B G Wolthers; Y Nordmann; J C Deybach; B Grandchamp; S K Wadman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Protoporphyric disorder in livers of broiler chickens.

Authors:  M Shiozawa; T Miyazawa; T Koeda; M Takahashi; H Fujiwara
Journal:  J Vet Med Sci       Date:  1995-06       Impact factor: 1.267

7.  Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.

Authors:  R Kauppinen; S Mustajoki; H Pihlaja; L Peltonen; P Mustajoki
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

8.  Erythropoietic porphyria of the fox squirrel Sciurus niger.

Authors:  E Y Levin; V Flyger
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

9.  Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.

Authors:  R L Lindberg; C Porcher; B Grandchamp; B Ledermann; K Bürki; S Brandner; A Aguzzi; U A Meyer
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

10.  Acute intermittent porphyria: alternative splicing of hydroxymethylbilane synthase mRNA excludes exons 3 and 12.

Authors:  P M Ong; W G Lanyon; M R Moore; J M Connor
Journal:  Mol Cell Probes       Date:  1998-04       Impact factor: 2.365

View more
  12 in total

1.  Web resource on available DNA variant tests for hereditary diseases and genetic predispositions in dogs and cats: An Update.

Authors:  Jennifer L Rokhsar; Julia Canino; Karthik Raj; Scott Yuhnke; Jeffrey Slutsky; Urs Giger
Journal:  Hum Genet       Date:  2021-02-06       Impact factor: 4.132

2.  Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.

Authors:  Makiko Yasuda; Angelika L Erwin; Lawrence U Liu; Manisha Balwani; Brenden Chen; Senkottuvelan Kadirvel; Lin Gan; M Isabel Fiel; Ronald E Gordon; Chunli Yu; Sonia Clavero; Antonios Arvelakis; Hetanshi Naik; L David Martin; John D Phillips; Karl E Anderson; Vaithamanithi M Sadagoparamanujam; Sander S Florman; Robert J Desnick
Journal:  Mol Med       Date:  2015-06-05       Impact factor: 6.354

3.  Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.

Authors:  Sonia Clavero; David F Bishop; Urs Giger; Mark E Haskins; Robert J Desnick
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

Review 4.  Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

Authors:  Makiko Yasuda; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2019-01-18       Impact factor: 4.797

5.  Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes.

Authors:  David F Bishop; Sonia Clavero; Narla Mohandas; Robert J Desnick
Journal:  Mol Med       Date:  2011-02-25       Impact factor: 6.354

Review 6.  Genetic testing in domestic cats.

Authors:  Leslie A Lyons
Journal:  Mol Cell Probes       Date:  2012-04-21       Impact factor: 2.365

7.  A web resource on DNA tests for canine and feline hereditary diseases.

Authors:  Jeffrey Slutsky; Karthik Raj; Scott Yuhnke; Jerold Bell; Neale Fretwell; Ake Hedhammar; Claire Wade; Urs Giger
Journal:  Vet J       Date:  2013-04-11       Impact factor: 2.688

Review 8.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

9.  Diagnosis of feline acute intermittent porphyria presenting with erythrodontia requires molecular analyses.

Authors:  Sonia Clavero; Yuri Ahuja; David F Bishop; Brittany Kwait; Mark E Haskins; Urs Giger; Robert J Desnick
Journal:  Vet J       Date:  2013-10-10       Impact factor: 2.688

10.  Cystinuria Associated with Different SLC7A9 Gene Variants in the Cat.

Authors:  Keijiro Mizukami; Karthik Raj; Carl Osborne; Urs Giger
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.